P V Avdonin Selected Research

P V Avdonin Research Topics

4	Traumatic Shock 05/2009 - 05/2006
3	Shock 05/2009 - 01/2007
2	COVID-19 01/2022 - 01/2022
2	Necrosis 01/2015 - 01/2010
2	Thromboembolism 01/2010 - 01/2005
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2006 - 01/2005
2	Thrombophilia 01/2005 - 01/2002
1	Coronavirus Infections 01/2022
1	Thrombotic Thrombocytopenic Purpura 07/2019
1	Rare Diseases (Rare Disease) 07/2019
1	Thrombotic Microangiopathies 07/2019
1	Inflammation (Inflammations) 01/2014
1	Hypersensitivity (Allergy) 01/2014
1	Wounds and Injuries (Trauma) 05/2006
1	Hypertension (High Blood Pressure) 02/2001

4	Serotonin (5 Hydroxytryptamine)IBA 01/2014 - 05/2006
3	Vasoconstrictor AgentsIBA 05/2009 - 01/2007
2	Famotidine (Pepcid)FDA LinkGeneric 01/2022 - 01/2022
2	Oseltamivir (Tamiflu)FDA Link 01/2022 - 01/2022
2	Prothrombin (Factor II)IBA 01/2006 - 01/2005
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2022
1	Metalloproteases (Metalloproteinases)IBA 07/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2015
1	AnticoagulantsIBA 01/2010
1	Serotonin ReceptorsIBA 03/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2007
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2007
1	GlucocorticoidsIBA 01/2007
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2007
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 05/2006
1	Vasopressins (Vasopressin)IBA 05/2006
1	Angiotensin IIIBA 05/2006
1	Hemostatics (Antihemorrhagics)IBA 01/2005
1	Factor V (Coagulation Factor V)IBA 01/2005
1	EnzymesIBA 01/2005
1	Protein CIBA 01/2005
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2005
1	Fibrinogen (Factor I)FDA Link 01/2005
1	Antithrombin IIIIBA 01/2005
1	Triethylenephosphoramide (TEPA)IBA 01/2005
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2005
1	Pharmaceutical PreparationsIBA 02/2001
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2001

4	Therapeutics 01/2022 - 01/2002
2	Plasmapheresis 01/2010 - 01/2002
1	Renal Dialysis (Hemodialysis) 01/2010